Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR-52.9%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
-52.9%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
20255.85%
20242.96%
2023-2.46%
202255.86%
2021-279.49%
2020-36.14%
2019-9.89%
2018-41.95%
2017-35.13%
2016-147.35%